MedTrace Logo

Glaucoma Surgery Using the ViaLase Laser System

NCT04949802 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2023-10-17

Study results available
· View outcomes & findings →

Summary

Prospective, single-center, multi-cohort clinical trial of ViaLase Laser for the reduction of IOP in patients with open angle glaucoma.

Conditions

Interventions

DEVICE

ViaLase Laser

ViaLase Laser System to create an aperture through the trabecular meshwork for the reduction of IOP in subjects with primary open-angle glaucoma

Sponsors & Collaborators

  • Vialase, Inc.

    lead INDUSTRY

Principal Investigators

  • Melvin Sarayba, MD · Vialase, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2021-12-16
Completion
2021-12-16
FDA Device
Yes

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04949802 on ClinicalTrials.gov